![A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-023-00892-5/MediaObjects/13555_2023_892_Fig2_HTML.png)
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
![Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.9b00533/asset/images/large/jm9b00533_0025.jpeg)
Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases | Journal of Medicinal Chemistry
![A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b01397/asset/images/large/jm-2018-01397g_0002.jpeg)
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
![The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology](https://www.jacionline.org/cms/asset/e4e0edfa-47b0-4dac-9e26-86e52ebf2400/gr1.jpg)
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology
![A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances](https://www.science.org/cms/10.1126/sciadv.abo4363/asset/23e53306-8cfe-42ea-9f0b-cd545b9364ed/assets/images/large/sciadv.abo4363-f1.jpg)
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances
![A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-023-00892-5/MediaObjects/13555_2023_892_Fig1_HTML.png)
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink
![JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd.2017.201/MediaObjects/41573_2017_Article_BFnrd2017201_Fig2_HTML.jpg)
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery
![A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c7e946c6-d795-4371-929f-e8d1c041ae8e/art41906-fig-0001-m.jpg)
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library
![Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology](https://www.gastrojournal.org/cms/asset/80839385-b019-483a-93f6-59ca4fc6809c/gr1.jpg)
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
![Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists](https://www.frontiersin.org/files/MyHome%20Article%20Library/437721/437721_Thumb_400.jpg)